# Fluticasone propionate and Salmeterol

NDC: 69097-661
Generic name: Fluticasone propionate and Salmeterol
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER
Routes: RESPIRATORY (INHALATION)
Marketing started: 20260727

FDA application: ANDA213087

## Active ingredients

- FLUTICASONE PROPIONATE: 250 ug/1
- SALMETEROL XINAFOATE: 50 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-661"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-661
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1349a04c-2024-42b9-b81d-a7d995716ade